Evidence map›Paper›PMID 35533246›Full record

ArticleHealth promotion practice2023

High Impact for Whom? A Qualitative Analysis of Organization Concerns About the Transition to High-Impact Prevention Policy.

Miranda J Reid, Emmanuel K Tetteh, Lucy M Ingaiza, Cory D Bradley, M Margaret Dolcini, Virginia R McKay

Abstract read
In one paragraph

Article in Health promotion practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Miranda J ReidWashington University in St. Louis, St. Louis, MO, USA.
Emmanuel K TettehWashington University in St. Louis, St. Louis, MO, USA.
Lucy M IngaizaWashington University in St. Louis, St. Louis, MO, USA.
Cory D BradleyWashington University in St. Louis, St. Louis, MO, USA.
M Margaret DolciniSchool of Social and Behavioral Health Sciences, College of Public Health and Human Sciences, Oregon State University, Corvallis, OR, USA.
Virginia R McKayWashington University in St. Louis, St. Louis, MO, USA.ORCID 0000-0002-9299-3294
Washington University in St. Louis · USOregon State University · US

Funding

A community dissemination intervention to increase the reach of current HIV testing systems: An exploratory studyR34MH120512 · NIMH · OREGON STATE UNIVERSITY · PI DOLCINI, M. MARGARET · 2020 to 2021
$609k
De-implementation of Low-value HIV Prevention InterventionsR21MH115772 · NIMH · WASHINGTON UNIVERSITY · PI MCKAY, VIRGINIA R · 2017 to 2018
$419k
NIMH NIH HHS R21 MH115772NIMH NIH HHS R34 MH120512
6 · The paper itself

Abstract

HIV represents a significant health burden in the United States. In 2012, the Centers for Disease Control and Prevention (CDC) stopped recommending many once-promoted interventions as part of a shift from one HIV intervention policy, Diffusion of Effective Behavioral Interventions (DEBI), to another, High Impact Prevention (HIP). Twenty-nine staff members from 10 organizations were interviewed to explore how organizations reacted to this shift. Three major themes emerged: (1) Personal experience, community assessment, and epidemiological evidence influenced organizations' perceptions of efficacy and preference for earlier interventions. (2) Organizations were concerned that HIP interventions were not a good fit for their priority populations. (3) Organizations were frustrated with the top-down approach by the CDC prioritizing HIP interventions over earlier interventions. These results indicate that organizations continue to see value in and provide DEBI interventions. In addition, a more participatory process incorporating qualitative evidence and organizations' experiences may be necessary to achieve widespread de-implementation of DEBI interventions.

Indexed as

HIV InfectionsCenters for Disease Control and Prevention, U.S.HumansPolicyUnited Stateshigh-impact preventionHIPHIV/AIDSimplementation science

Identifiers

PMID35533246
PMCPMC13158712
OpenAlexW4229373048

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.